Blogs about Biotechnology, Pharmaceutical and Healthcare

06:59 EDT 23rd October 2014 | BioPortfolio

Read the latest opinions - blogs from pharmaceutical and life science industry experts.

Showing News Articles 1–25 of 62,000+

Thursday 23rd October 2014

Interview: The Problem with Cancer Vaccines

You can’t treat a heterogeneous disease with a homogeneous treatment. That was the takeawy message from Vaccinogen’s founder at the World Vaccines Congress Europe Vaccine Nation caught up with Michael Hanna, the founder of Vaccinogen and creator of autologous patient-specific tuumor cell vaccine OncoVAX, to discuss why ther have been so many highprofile cancer vaccine failures and [&...

Regulatory Tsunami?

Medicare is working hard to make sure that doctors are efficiently providing high-quality care. Programs such as the Physician Quality Reporting System (PRQS) and the Value-Based Payment Modifier all are aimed to improve quality and lower cost. The d...

Wednesday 22nd October 2014

Top stories in health and medicine, October 23, 2014

From MedPage Today: Aortic Dissection Becoming Less Deadly. Aortic dissection survival has improved, particularly for patients getting surgical repair. Preparing for Ebola: Is New York City Ready? The hall was packed, the speakers were primed, and the message to thousands of healthcare workers gathered here today was simple: Ebola will not sneak up on the Big […]

Amarin's Value With Or Without REDUCE-IT And A Final Word On Management

Regulus Therapeutics' (RGLS) CEO Kleanthis Xanthopoulos Hosts RG-101 Human Proof of Concept Call (Transcript)

S-ICD Sales Exceeding Expectations, Boston Scientific Reports

The company said when it launched that it expected S-ICD to be a major growth driver, and that appears to be working out so far. The company now expects the leadless implantable defibrillator to bring in $100 million in revenue this year.

Ensuring GSK Consumer Products Take Leading Position Touted In Management Shift

GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and genera...

Medical history: Compiling your medical family tree

Asthma: Limit asthma attacks caused by colds or flu

Xtandi Japan Label Change Worth $45m to Medivation

What’s the worth of words? Forty-five million dollars if you are Medivation, which will benefit from a milestone payment of that amount from partner Astellas Pharma in relation to a Japanese labeling change for prostate cancer drug Xtandi (enzaluta...

Varian Medical Systems' (VAR) CEO Dow Wilson on F4Q 2014 Results - Earnings Call Transcript

How Medicare 'Self-Referral' Thrives on Loophole

A Florida medical group shows how doctors can order Medicare-funded procedures from entities in which they have financial interests, despite a decades-old federal law seeking to ban most ‘self-referral.’

Sangamo Biosciences' (SGMO) CEO Edward Lanphier on Q3 2014 Results - Earnings Call Transcript

IPC The Hospitalist's (IPCM) CEO Adam Singer on Q3 2014 Results - Earnings Call Transcript

10-minute Ebola test announced

San Diego's Genalyte says test works on its commercially available platform.

C. R. Bard's (BCR) CEO Timothy Ring on Q3 2014 Results - Earnings Call Transcript

Edico starts selling high-powered genome processor

A super-fast genome processer is now on sale by San Diego's Edico Genome.

J&J, GSK, Tekmira, And Others Take Next Steps To Fight Ebola

There’s been distressing Ebola-related news in recent days. The deadly virus continues to spread in West Africa, with more than 4,500 fatalities now reported, and efforts to halt its spread in the U.S. have been mired in controversy and confusi...

BIO Patient & Health Advocacy Summit: The Power of Partnerships

Last week, the BIO Patient & Health Advocacy Summit powered partnerships in the industry to advance drug discovery by bringing together patient and advocacy groups, government agencies and biotech industry leaders to discuss how to accelerate med...

GlaxoSmithKline's (GSK) CEO Andrew Witty on Q3 2014 Results - Earnings Call Transcript

NIST's Cloud Computing Roadmap details research requirements and action plans

The National Institute of Standards and Technology (NIST) has published the final version of the US Government Cloud Computing Technology Roadmap, Volumes I and II. The roadmap focuses on strategic and tactical objectives to support the federal gover...

Time In The Market Is More Important Than Timing The Market

Abbott Sales Rise, Mylan Deal Tweaked

Abbott tweaked the terms of its agreement to sell a portion of its generic-drugs business to Mylan for $5.3 billion, signaling the deal will be completed despite new Treasury department rules.

India Brandishes Study Discrediting U.S. IP Index

A new study by academia, at the behest of leading Indian firms, has, among other observations, found flaws in the United States Chamber of Commerce's Global Intellectual Property Center (GIPC) International IP index.

Conformity Assessment On Way Out For Many Australian Devices

The Australian government will soon amend its regulations to allow most local medical device manufacturers to rely on conformity assessments by European notified bodies. The change is welcome news for the industry, which has long been pushing for a c...

Search BioPortfolio: